Slc6A1 Protein — Gaba Transporter 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SLC6A1 (GABA Transporter 1, GAT-1) is a sodium-dependent GABA transporter that regulates GABA signaling in the brain by reuptaking GABA into [neurons](/entities/neurons) and glia. It plays critical roles in inhibitory neurotransmission and is implicated in epilepsy and other neurological disorders.
Structure
SLC6A1 has the classic SLC6 transporter fold:
...
SLC6A1 Protein — GABA Transporter 1
Introduction
Slc6A1 Protein — Gaba Transporter 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SLC6A1 (GABA Transporter 1, GAT-1) is a sodium-dependent GABA transporter that regulates GABA signaling in the brain by reuptaking GABA into [neurons](/entities/neurons) and glia. It plays critical roles in inhibitory neurotransmission and is implicated in epilepsy and other neurological disorders.
Structure
SLC6A1 has the classic SLC6 transporter fold:
12 Transmembrane Domains: Alpha-helices that form the translocation pathway
N-terminal and C-terminal Intracellular Loops: Important for trafficking and regulation
Sodium Binding Sites: Multiple Na+ binding sites required for transport
GABA Binding Site: Central binding pocket that alternates between outward- and inward-facing conformations
Chloride Ion Binding Site: Cl- ions are co-transported with GABA and Na+
The transporter operates via the alternating access mechanism, transitioning between outward-facing and inward-facing conformations.
Normal Function
GAT-1 performs essential functions in GABAergic signaling:
GABA Reuptake: Clears GABA from the synaptic cleft after neurotransmission, terminating the signal<sup>[1]</sup>.
GABA Recycling: Transport GABA back into presynaptic neurons for reuse or into glial cells for metabolism.
Maintenance of Inhibitory Tone: Precisely controls extracellular GABA levels to maintain proper inhibition.
Presynaptic Regulation: Regulates presynaptic GABA release through transporter activity.
Protection against Excitotoxicity: Prevents excessive extracellular GABA that could cause paradoxical excitation.
Role in Disease
Epilepsy
GAT-1 dysfunction contributes to epilepsy pathogenesis
Reduced GAT-1 function leads to impaired GABA clearance and hyperexcitability
GAT-1 knockout mice exhibit spontaneous seizures
Tiagabine (GAT-1 inhibitor) can cause seizures as side effect
Myoclonic Atonic Epilepsy (MAE)
SLC6A1 mutations cause a spectrum of epileptic encephalopathies
Affected individuals have myoclonic-astatic seizures
Developmental delay and intellectual disability common
Alzheimer's Disease
Altered GAT-1 expression in AD brains may contribute to network dysfunction
GABAergic dysfunction correlates with cognitive decline
Targeting GAT-1 explored as therapeutic approach
Parkinson's Disease
GAT-1 in basal ganglia regulates inhibitory output
Modulation affects motor symptoms
GAT-1 inhibitors explored as adjunct therapy
Therapeutic Targeting
GAT-1 is a proven therapeutic target:
Tiagabine: Selective GAT-1 inhibitor used as anticonvulsant
Nirmezumab: Anti-GAT-1 antibody being investigated for epilepsy
Small Molecule Modulators: GAT-1 enhancers for cognitive enhancement
Note: GAT-1 inhibitors must be used carefully as excessive GABA elevation can cause paradoxical effects.
Interactions
SLC6A1 interacts with:
GABA: Primary substrate
Sodium (Na+): Required co-transport ion
Chloride (Cl-): Co-transported ion
Protein Kinases: PKC regulates transporter activity
Neuronal Interactors: Synaptic scaffolding proteins for localization
See Also
[SLC6A1 Gene](/genes/slc6a1)
[GABA Signaling in the Brain](/mechanisms/gaba-signaling-pathway)
The study of Slc6A1 Protein — Gaba Transporter 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data